1-160277128-CAG-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The ENST00000368072.10(PEX19):c.*2421_*2422del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 453,440 control chromosomes in the GnomAD database, including 25 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0075 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 6 hom. )
Consequence
PEX19
ENST00000368072.10 3_prime_UTR
ENST00000368072.10 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.148
Genes affected
PEX19 (HGNC:9713): (peroxisomal biogenesis factor 19) This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00749 (1135/151444) while in subpopulation AFR AF= 0.0261 (1077/41300). AF 95% confidence interval is 0.0248. There are 19 homozygotes in gnomad4. There are 549 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX19 | NM_002857.4 | c.*2421_*2422del | 3_prime_UTR_variant | 8/8 | ENST00000368072.10 | NP_002848.1 | ||
PEX19 | NM_001193644.1 | c.*2429_*2430del | 3_prime_UTR_variant | 8/8 | NP_001180573.1 | |||
PEX19 | NR_036492.2 | n.3220_3221del | non_coding_transcript_exon_variant | 7/7 | ||||
PEX19 | NR_036493.2 | n.3244_3245del | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX19 | ENST00000368072.10 | c.*2421_*2422del | 3_prime_UTR_variant | 8/8 | 1 | NM_002857.4 | ENSP00000357051 | P1 | ||
PEX19 | ENST00000472750.5 | c.*3088_*3089del | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 1 | ENSP00000434633 |
Frequencies
GnomAD3 genomes AF: 0.00746 AC: 1130AN: 151376Hom.: 18 Cov.: 32
GnomAD3 genomes
AF:
AC:
1130
AN:
151376
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00146 AC: 188AN: 129016Hom.: 5 AF XY: 0.00110 AC XY: 78AN XY: 70606
GnomAD3 exomes
AF:
AC:
188
AN:
129016
Hom.:
AF XY:
AC XY:
78
AN XY:
70606
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00105 AC: 317AN: 301996Hom.: 6 AF XY: 0.000779 AC XY: 134AN XY: 172110
GnomAD4 exome
AF:
AC:
317
AN:
301996
Hom.:
AF XY:
AC XY:
134
AN XY:
172110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00749 AC: 1135AN: 151444Hom.: 19 Cov.: 32 AF XY: 0.00743 AC XY: 549AN XY: 73888
GnomAD4 genome
AF:
AC:
1135
AN:
151444
Hom.:
Cov.:
32
AF XY:
AC XY:
549
AN XY:
73888
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Peroxisome biogenesis disorder 1A (Zellweger) Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at